Novel AML product candidate granted orphan drug designation by FDA
Novel product candidate M2T-CD33 (LTI-214) was granted orphan drug designation by the US Food and Drug Administration for the treatment of acute myeloid
Leukemia
Acute Myeloid Leukemia
Leukemia News
SOHO 2025
Dr. Jabbour discusses investigational menin inhibitor bleximenib
In this interview at the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), Elias Jabbour, MD, leukemia professor at the
Leukemia News
SOHO 2025
Leukemia
Chronic Lymphocytic Leukemia
Obesity increases infection risk in CLL for patients treated with a BTKi
Patients with chronic lymphocytic leukemia (CLL) who have a body mass index (BMI) of 40 or higher (obesity class 3) are at a
Leukemia
Chronic Lymphocytic Leukemia
SOHO Insider Podcast
Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL
In this episode of the SOHO Insider podcast, Susan O’Brien, MD, a professor of medicine from the Chao Family Comprehensive Cancer Center at
Leukemia
Acute Myeloid Leukemia
FDA approves revumenib in relapsed or refractory NMP1-mutated AML
The US Food and Drug Administration (FDA) has approved revumenib (Revuforj®) in patients with relapsed or refractory NPM1-mutated acute myeloid leukemia (AML). The
ESMO 2025
Acute Lymphoblastic Leukemia
Aggressive B-Cell Lymphomas
Multiple Myeloma
Myelodysplastic Syndromes
Despite digital advances, cancer research remains costly, burdensome
Clinical cancer research remains too expensive and too burdensome, even amid a proliferation of digital tools designed to improve it, according to Ines
ESMO 2025
Myelodysplastic Syndromes
News
Bexmarilimab continues to show strong efficacy in phase 1/2 trial update
Updated results from a phase 1/2 trial of bexmarilimab plus azacitidine continue to support the efficacy of the combination in treatment-naïve patients with
MDS News
SOHO 2025
News
VERONA phase 3 trial shows no survival benefit in high-risk MDS
The study, presented by Guillermo Garcia-Manero, MD, interim chair of the Department of Leukemia at the University of Texas MD Anderson Cancer Center,
SBBC
Multiple Myeloma
SOHO Insider Podcast
Video Interviews
Society Updates
Sagar Lonial, MD, on what to expect at SOHO Breakthroughs in Blood Cancers
Sagar Lonial, MD, and Saad Usmani, MD, provide a sneak peek on what attendees can expect to learn at SOHO Breakthroughs in Blood
Multiple Myeloma
News
World-renowned hematologist Brian G.M. Durie, MD, has died at the age of 82
World-renowned hematologist Brian G.M. Durie, MD, has died at the age of 82. Dr. Durie's death was announced on October 14, 2025, in